Sponsor Pipeline

Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
8
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-03 NCT07741435 Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and… Recruiting
Active Trials by Phase
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT07633626 Vortioxetine for Cognitive Function in ALK-positive NSCLC Treated With Lorlatinib Advanced ALK/ROS1-positive NSCLC Recruiting
NCT07676461 Oral, Fecal and Intratumoral Microbiome Atlas in Colombian Patients With Advanced Solid… Gastric Cancer Recruiting
NCT07741435 Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and… Neoplasms Recruiting
NCT05998993 Study to Evaluate SBRT for EGFR Mutant NSCLC Patients Receiving Osimertinib (CULTRO) EGF-R Positive Non-Small Cell Lung Cancer Not Yet Recruiting
Disease Areas
Lung Cancer (3) Non-Small Cell Lung Cancer (NSCLC) (2) Breast Cancer (2) Colorectal Cancer (2) Cervical Cancer (2) Depression (1) Gastric Cancer (1) Head & Neck Cancer (1)
Get alerts when Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free